Taiga Biotechnologies, Inc. is a clinical stage biotechnology company focused on harnessing the power of the immune system to fight solid tumors and infectious disease and on improving blood stem cell transplantation
OUR MISSION
Developing treatments for the drug resistant world
OUR LEADERSHIP
Yosef Refaeli, Ph.D.
Chief Executive Officer
Co-Founder
Brian Turner, Ph.D.
President & Chief Scientific Officer
Co-Founder
James Kelly
Chief Financial Officer
Robert Gulock
Chief Commercial Officer
